Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Arcutis Biotherapeutics (ARQT)
December 12 2022 - 01:11PM
TipRanks
There's a lot to be optimistic about in the Healthcare sector as 3
analysts just weighed in on Crispr Therapeutics AG (CRSP – Research
Report), Arcutis Biotherapeutics (ARQT – Research Report) and
Gamida Cell (GMDA – Research Report) with bullish sentiments.
Crispr Therapeutics AG (CRSP) Brookline Capital Markets analyst
Leah R. Cann initiated coverage with a Buy rating on Crispr
Therapeutics AG today and set a price target of $143.00. The
company's shares closed last Monday at $50.09. According to
TipRanks.
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-crispr-therapeutics-ag-crsp-arcutis-biotherapeutics-arqt?utm_source=advfn.com&utm_medium=referral
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Sep 2023 to Oct 2023
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Oct 2022 to Oct 2023